| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $14,426,634 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152183 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study) | 000 | 3 | NIH | 3/27/2023 | $192,361 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152183 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study) | 000 | 3 | NIH | 3/27/2023 | $137,715 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI143636 | Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB | 000 | 4 | NIH | 2/14/2023 | $794,603 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 002 | 4 | NIH | 7/6/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D71TW012568 | Developing an in vivo infectious disease training program at the University of Cape Town | 000 | 1 | NIH | 8/28/2023 | $109,774 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011943 | Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa | 000 | 3 | NIH | 5/1/2023 | $50,585 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 002 | 4 | NIH | 7/6/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U24HG012750 | African Genomics Data Hub Biomedical Knowledgebase | 000 | 1 | NIH | 8/28/2023 | $640,582 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01TW012626 | INnovative data Science to Impact the TB Epidemic - INSITE | 000 | 1 | NIH | 8/28/2023 | $1 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011943 | Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa | 000 | 3 | NIH | 5/1/2023 | $50,000 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 001 | 4 | NIH | 6/21/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01TW012626 | INnovative data Science to Impact the TB Epidemic - INSITE | 000 | 1 | NIH | 8/28/2023 | $244,783 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R61DA053736 | Cape Town Adolescent Antiretroviral Cohort- Substance, Imaging, Mental Health (CTAAC-SIM) | 000 | 3 | NIH | 6/20/2023 | $358,953 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 001 | 4 | NIH | 6/21/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D43TW010559 | HIV-associated Tuberculosis Training Program (HATTP) | 002 | 7 | NIH | 4/21/2023 | $244,153 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01MH132950 | 3/3 Akili: Phenotypic and genetic characterization of ADHD in Kenya and South Africa | 001 | 1 | NIH | 9/4/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01MH132950 | 3/3 Akili: Phenotypic and genetic characterization of ADHD in Kenya and South Africa | 000 | 1 | NIH | 7/26/2023 | $539,996 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI160501 | Targeting non-coding RNAs as host-directed drug therapy for tuberculosis | 000 | 3 | NIH | 3/3/2023 | $131,642 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH125053 | 3/3 Genomics of Schizophrenia in the South African Xhosa | 000 | 3 | NIH | 3/2/2023 | $752,229 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 000 | 4 | NIH | 5/11/2023 | $279,568 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D43TW010559 | HIV-associated Tuberculosis Training Program (HATTP) | 002 | 7 | NIH | 4/21/2023 | $50,000 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D71TW012504 | A Training Development Plan for HIV-associated Behavioural Medicine | 000 | 1 | NIH | 3/1/2023 | $5,240 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D71TW012504 | A Training Development Plan for HIV-associated Behavioural Medicine | 000 | 1 | NIH | 3/1/2023 | $25,000 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011436 | Impact of asymptomatic sexually transmitted infections and interferon agonists on the susceptibility of foreskin primary cells to HIV-1 infection. | 001 | 4 | NIH | 9/6/2023 | $99,998 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 000 | 4 | NIH | 5/11/2023 | $53,791 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01AI152153 | Maximizing the success of HIV+ to HIV+ kidney transplantation in South Africa | 000 | 4 | NIH | 5/12/2023 | $171,428 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01MH131022 | Early brain development in children born to depressed mothers in high and low income settings | 000 | 2 | NIH | 8/10/2023 | $328,143 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R21HD110305 | Influence of fetal antiretroviral exposure on gut microbiota, systemic inflammation and neurodevelopment in infants exposed to HIV | 000 | 1 | NIH | 2/16/2023 | $177,815 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011436 | Impact of asymptomatic sexually transmitted infections and interferon agonists on the susceptibility of foreskin primary cells to HIV-1 infection. | 000 | 4 | NIH | 7/30/2023 | $112,658 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01AI152151 | Characterizing intact proviral HIV-1 reservoir size and determinants of reservoir dynamics in African populations | 001 | 4 | NIH | 3/15/2023 | $174,952 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R34MH126702 | Building Resources to Achieve Improvement in Neurocognition (B.R.A.I.N.) inpeople with HIV. | 001 | 2 | NIH | 3/1/2023 | $232,581 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152092 | Repurposing kinase inhibitor chemotypes as antimalarials | 000 | 4 | NIH | 3/13/2023 | $112,199 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152092 | Repurposing kinase inhibitor chemotypes as antimalarials | 000 | 4 | NIH | 3/13/2023 | $178,500 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U24HL135600 | Sickle Africa Data Coordinating Center | 000 | 7 | NIH | 8/16/2023 | $955,954 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01AI152103 | Influence of high-dose rifampin on Mycobacterial load and inflammatory mediators in pericardial TB patients | 000 | 4 | NIH | 5/2/2023 | $199,994 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011434 | Undetectable and Untransmittable: reducing HIV transmission among young women living with HIV, their partners and children in South Africa | 000 | 5 | NIH | 4/25/2023 | $60,776 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R25TW012219 | Establishing an MSc in Global Health Ethics at the University of Cape Town | 000 | 2 | NIH | 2/24/2023 | $212,265 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152118 | Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate. | 002 | 4 | NIH | 7/26/2023 | $286,102 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011434 | Undetectable and Untransmittable: reducing HIV transmission among young women living with HIV, their partners and children in South Africa | 000 | 5 | NIH | 4/25/2023 | $50,000 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U2CEB032224 | eLwazi Open Data Science Platform and Coordinating Center | 000 | 3 | NIH | 9/12/2023 | $2,208,187 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011442 | Psychosocial distress, inflammatory reactivity and central sensitization in the pathway to HIV-related pain: characterizing the associations and developing a pragmatic, coping-focused intervention. | 000 | 5 | NIH | 4/10/2023 | $98,612 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 001 | 17 | NIH | 5/30/2023 | $329,187 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 001 | 17 | NIH | 5/30/2023 | $888,264 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D43TW011950 | Program ARISE2: African mental health Researchers Inspired and Equipped | 000 | 3 | NIH | 7/19/2023 | $239,467 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH127692 | Public Understanding of Big data in Genomics Medicine in Africa (PUBGEM-Africa) | 000 | 3 | NIH | 8/23/2023 | $100,000 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D43TW011308 | Building Research in Inter-Disciplinary Gender and HIV through the Social Sciences (The BRIDGES Programme) | 002 | 5 | NIH | 9/13/2023 | $99,849 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D43TW011308 | Building Research in Inter-Disciplinary Gender and HIV through the Social Sciences (The BRIDGES Programme) | 001 | 5 | NIH | 3/22/2023 | $251,485 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 000 | 17 | NIH | 11/25/2022 | $329,188 |
| | 2023 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 000 | 17 | NIH | 11/25/2022 | $427,911 |
|
